Spatial Genomics and Transcriptomics Market by Technique (Spatial Transcriptomics, and Spatial Genomics Analysis), Product Type (Instruments, Consumables, and Software), Application, (Translational Research, and Drug Discovery & Development) and End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021–2030
The global spatial genomics and transcriptomics market was valued at $626.9 million in 2020 and is projected to reach $2,159.61 million by 2030, registering a CAGR of 13.6% from 2021 to 2030.
The studies of all genes and their associated mRNAs are correspondingly called genomics and transcriptomics. It is a method usually designed to assign cell types (mainly identified by mRNA readouts) to their locations in histological sections. This method can also be used to determine subcellular localization of mRNA molecules and their cellular heterogeneity in tissues, and tumors. In addition, spatial genomics and transcriptomics also provides information regarding immune cells as well as determine subcellular distribution of transcripts in various conditions.
Spatial genomics has tremendous potential in disease control as it helps to provide quantitative gene expression results, coupled with DNA & RNA visualization mapping within tissue parts. In spatial transcriptomics, sequencing techniques have a major share due to wide availability of sequencing platforms that help study RNA architecture in tissues or cells and use of advanced techniques within a laboratory setup to study biological organisms, which needs trained experts such as researchers and technicians. Genomics provides an overview of the complete set of genetic instructions provided by the DNA, while transcriptomics looks into gene expression patterns. The main driving factor that drives growth of the spatial genomics and transcriptomics market include, increase in adoption of spatial genomics and transcriptomics owing to its various application.
In addition, rise in prevalence of genetic disorders and applications of spatial genomics and transcriptomics in determination of disease and treatment markers, further supplement the global spatial genomics and transcriptomics market growth. Furthermore, growing preference toward personalized medicines also fuels growth of the market.
Conversely, unavailability of skilled professionals and ethical & legal limitations associated with the use of spatial genomics and transcriptomics technologies are expected to obstruct the growth of the market during forecast years. On the other hand, growth in innovations in spatial genomics and transcriptomics technologies are expected to offer profitable opportunities for the growth of the market during the forecast period.
The global spatial genomics and transcriptomics market is segmented on the basis of technique, product type, application, end user and region to provide a detailed assessment of the market. By technique, it is bifurcated into spatial transcriptomics, and spatial genomics analysis. The spatial transcriptomics is segmented into microdissection, fluorescent in-situ hybridization, in-situ sequencing, in-situ capturing, and in-silico construction.
In addition, the spatial genomics analysis is segmented into, fluorescence in-situ sequencing, and fluorescence microscopy. By product type, it is segmented into instruments, consumables, and software. By application, it is divided into, translational research, and drug discovery & development. Based on end user, it is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key market players profiled in the report include 10X Genomics, Inc., Akoya Biosciences, Inc., BioSpyder Technologies Inc., Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.), Dovetail Genomics, LLC, Fluidigm Corporation, Genomic Vision SA, Illumina, Inc., Lunaphore Technologies SA, Nanostring Technologies, Inc., Natera Inc., PerkinElmer Inc. (Horizon Discovery Group Plc), Rarecyte, Inc., Rebus Biosystems, LLC, Resolve Biosciences, S2 Genomic, Seven Bridges Genomics, Singular Genomics System, Inc., Tecan Group Ltd. (Nugen Technologies, Inc.), Ultivue, Inc., Veranome Biosystems LLC, and Vizgen Corporation.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global spatial genomics and transcriptomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps to understand the application and products of spatial genomics and transcriptomics used across the globe.
Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Technique
Spatial Transcriptomics
Microdissection
Fluorescent In-situ hybridization
In-situ sequencing
In-situ capturing
In-silico construction
Spatial Genomics Analysis
Fluorescence In-situ sequencing
Fluorescence Microscopy
By Product Type
Instruments
Consumables
Software
By Application
Translational Research
Drug Discovery & Development
By End User
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutes
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Latin America
Middle East and Africa
LIST OF KEY PLAYERS PROFILED IN THE REPORT
10X Genomics, Inc.
Akoya Biosciences, Inc.
BioSpyder Technologies Inc.
Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.)
Dovetail Genomics, LLC
Fluidigm Corporation
Genomic Vision SA
Illumina, Inc.
Lunaphore Technologies SA
Nanostring Technologies, Inc.
Natera Inc.
PerkinElmer Inc. (Horizon Discovery Group Plc)
Rarecyte, Inc.
Rebus Biosystems, LLC
Resolve Biosciences
S2 Genomic
Seven Bridges Genomics
Singular Genomics System, Inc.
Tecan Group Ltd. (Nugen Technologies, Inc.)
Ultivue, Inc.
Veranome Biosystems LLC
Vizgen Corporation
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key benefits for stakeholders
- 1.3.Key market segments
- 1.3.1.List of key players profiled in the report
- 1.4.Research methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO perspective
- CHAPTER 3:MARKET LANDSCAPE
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.2.2.Top winning strategies
- 3.3.Porter’s five force analysis
- 3.4.Top player positioning, 2020
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.1.1.Increase in adoption of spatial genomics and transcriptomics technologies
- 3.5.1.2.Rise in prevalence of genetic disorders
- 3.5.1.3.Growth in preference toward personalized medicines
- 3.5.2.Restraints
- 3.5.2.1.Dearth of skilled professionals
- 3.5.2.2.Ethical & legal limitations
- 3.5.3.Opportunity
- 3.5.3.1.Growth in innovations in spatial genomics and transcriptomics technologies
- 3.5.4.Impact analysis
- 3.6.COVID-19 Impact analysis on the spatial genomics and transcriptomics market
- CHAPTER 4:SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE
- 4.1.Overview
- 4.1.1.Market size and forecast
- 4.2.Spatial Transcriptomics
- 4.2.1.Key market trends, growth factors, and opportunities
- 4.2.2.Market size and forecast, by region
- 4.2.3.Market analysis, by country
- 4.2.4.Market size and forecast, by type
- 4.2.5.Microdissection
- 4.2.5.1.Market size and forecast
- 4.2.6.Fluorescent In-situ hybridization
- 4.2.6.1.Market size and forecast
- 4.2.7.In-situ sequencing
- 4.2.7.1.Market size and forecast
- 4.2.8.In-situ capturing
- 4.2.8.1.Market size and forecast
- 4.2.9.In-silico construction
- 4.2.9.1.Market size and forecast
- 4.3.Spatial Genomics Analysis
- 4.3.1.Key market trends, growth factors, and opportunities
- 4.3.2.Market size and forecast
- 4.3.3.Market analysis, by country
- 4.3.4.Market size and forecast, by type
- 4.3.5.Fluorescence In-situ sequencing
- 4.3.5.1.Market size and forecast
- 4.3.6.Fluorescence Microscopy
- 4.3.6.1.Market size and forecast
- CHAPTER 5:SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE
- 5.1.Overview
- 5.1.1.Market size and forecast
- 5.2.Instruments
- 5.2.1.Market size and forecast, by region
- 5.2.2.Market analysis, by country
- 5.3.Consumables
- 5.3.1.Market size and forecast, by region
- 5.3.2.Market analysis, by country
- 5.4.Software
- 5.4.1.Market size and forecast, by region
- 5.4.2.Market analysis, by country
- CHAPTER 6:SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, APPLICATION
- 6.1.Overview
- 6.1.1.Market size and forecast
- 6.2.Translational Research
- 6.2.1.Market size and forecast, by region
- 6.2.2.Market analysis, by country
- 6.3.Drug Discovery & Development
- 6.3.1.Market size and forecast, by region
- 6.3.2.Market analysis, by country
- CHAPTER 7:SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER
- 7.1.Overview
- 7.1.1.Market size and forecast
- 7.2.Pharmaceutical & Biotechnology Companies
- 7.2.1.Market size and forecast, by region
- 7.2.2.Market analysis, by country
- 7.3.Contract Research Organizations
- 7.3.1.Market size and forecast
- 7.3.2.Market analysis, by country
- 7.4.Academic & Research Institutes
- 7.4.1.Market size and forecast
- 7.4.2.Market analysis, by country
- CHAPTER 8:SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY REGION
- 8.1.Overview
- 8.1.1.Market size and forecast
- 8.2.North America
- 8.2.1.Key market trends, growth factors, and opportunities
- 8.2.2.Market size and forecast, by country
- 8.2.2.1.U.S.
- 8.2.2.1.1.U.S. spatial genomics and transcriptomics market, by technique
- 8.2.2.1.2.U.S. spatial genomics and transcriptomics market, by product type
- 8.2.2.1.3.U.S. spatial genomics and transcriptomics market, by application
- 8.2.2.1.4.U.S. spatial genomics and transcriptomics market, by end user
- 8.2.2.2.Canada
- 8.2.2.2.1.Canada spatial genomics and transcriptomics market, by technique
- 8.2.2.2.2.Canada spatial genomics and transcriptomics market, by product type
- 8.2.2.2.3.Canada spatial genomics and transcriptomics market, by application
- 8.2.2.2.4.Canada spatial genomics and transcriptomics market, by end user
- 8.2.2.3.Mexico
- 8.2.2.3.1.Mexico spatial genomics and transcriptomics market, by technique
- 8.2.2.3.2.Mexico spatial genomics and transcriptomics market, by product type
- 8.2.2.3.3.Mexico spatial genomics and transcriptomics market, by application
- 8.2.2.3.4.Mexico spatial genomics and transcriptomics market, by end user
- 8.2.3.North America market size and forecast, by technique
- 8.2.3.1.North America market size and forecast, by spatial transcriptomics
- 8.2.3.2.North America market size and forecast, by spatial genomics analysis
- 8.2.4.North America market size and forecast, by product type
- 8.2.5.North America market size and forecast, by application
- 8.2.6.North America market size and forecast, by end user
- 8.3.Europe
- 8.3.1.Key market trends, growth factors, and opportunities
- 8.3.2.Market size and forecast, by country
- 8.3.2.1.Germany
- 8.3.2.1.1.Germany spatial genomics and transcriptomics market, by technique
- 8.3.2.1.2.Germany spatial genomics and transcriptomics market, by product type
- 8.3.2.1.3.Germany spatial genomics and transcriptomics market, by application
- 8.3.2.1.4.Germany spatial genomics and transcriptomics market, by end user
- 8.3.2.2.France
- 8.3.2.2.1.France spatial genomics and transcriptomics market, by technique
- 8.3.2.2.2.France spatial genomics and transcriptomics market, by product type
- 8.3.2.2.3.France spatial genomics and transcriptomics market, by application
- 8.3.2.2.4.France spatial genomics and transcriptomics market, by end user
- 8.3.2.3.UK
- 8.3.2.3.1.UK spatial genomics and transcriptomics market, by technique
- 8.3.2.3.2.UK spatial genomics and transcriptomics market, by product type
- 8.3.2.3.3.UK spatial genomics and transcriptomics market, by application
- 8.3.2.3.4.UK spatial genomics and transcriptomics market, by end user
- 8.3.2.4.Italy
- 8.3.2.4.1.Italy spatial genomics and transcriptomics market, by technique
- 8.3.2.4.2.Italy spatial genomics and transcriptomics market, by product type
- 8.3.2.4.3.Italy spatial genomics and transcriptomics market, by application
- 8.3.2.4.4.Italy spatial genomics and transcriptomics market, by end user
- 8.3.2.5.Spain
- 8.3.2.5.1.Spain spatial genomics and transcriptomics market, by technique
- 8.3.2.5.2.Spain spatial genomics and transcriptomics market, by product type
- 8.3.2.5.3.Spain spatial genomics and transcriptomics market, by application
- 8.3.2.5.4.Spain spatial genomics and transcriptomics market, by end user
- 8.3.2.6.Rest of Europe
- 8.3.2.6.1.Rest of Europe spatial genomics and transcriptomics market, by technique
- 8.3.2.6.2.Rest of Europe spatial genomics and transcriptomics market, by product type
- 8.3.2.6.3.Rest of Europe spatial genomics and transcriptomics market, by application
- 8.3.2.6.4.Rest of Europe spatial genomics and transcriptomics market, by end user
- 8.3.3.Europe market size and forecast, by technique
- 8.3.3.1.Europe market size and forecast, by spatial transcriptomics
- 8.3.3.2.Europe market size and forecast, by spatial genomics analysis
- 8.3.4.Europe market size and forecast, by product type
- 8.3.5.Europe market size and forecast, by application
- 8.3.6.Europe market size and forecast, by end user
- 8.4.Asia-Pacific
- 8.4.1.Key market trends, growth factors, and opportunities
- 8.4.2.Market size and forecast, by country
- 8.4.2.1.Japan
- 8.4.2.1.1.Japan spatial genomics and transcriptomics market, by technique
- 8.4.2.1.2.Japan spatial genomics and transcriptomics market, by product type
- 8.4.2.1.3.Japan spatial genomics and transcriptomics market, by application
- 8.4.2.1.4.Japan spatial genomics and transcriptomics market, by end user
- 8.4.2.2.China
- 8.4.2.2.1.China spatial genomics and transcriptomics market, by technique
- 8.4.2.2.2.China spatial genomics and transcriptomics market, by product type
- 8.4.2.2.3.China spatial genomics and transcriptomics market, by application
- 8.4.2.2.4.China spatial genomics and transcriptomics market, by end user
- 8.4.2.3.Australia
- 8.4.2.3.1.Australia spatial genomics and transcriptomics market, by technique
- 8.4.2.3.2.Australia spatial genomics and transcriptomics market, by product type
- 8.4.2.3.3.Australia spatial genomics and transcriptomics market, by application
- 8.4.2.3.4.Australia spatial genomics and transcriptomics market, by end user
- 8.4.2.4.India
- 8.4.2.4.1.India spatial genomics and transcriptomics market, by technique
- 8.4.2.4.2.India spatial genomics and transcriptomics market, by product type
- 8.4.2.4.3.India spatial genomics and transcriptomics market, by application
- 8.4.2.4.4.India spatial genomics and transcriptomics market, by end user
- 8.4.2.5.South Korea
- 8.4.2.5.1.South Korea spatial genomics and transcriptomics market, by technique
- 8.4.2.5.2.South Korea spatial genomics and transcriptomics market, by product type
- 8.4.2.5.3.South Korea spatial genomics and transcriptomics market, by application
- 8.4.2.5.4.South Korea spatial genomics and transcriptomics market, by end user
- 8.4.2.6.Rest of Asia-Pacific
- 8.4.2.6.1.Rest of Asia-Pacific spatial genomics and transcriptomics market, by technique
- 8.4.2.6.2.Rest of Asia-Pacific spatial genomics and transcriptomics market, by product type
- 8.4.2.6.3.Rest of Asia-Pacific spatial genomics and transcriptomics market, by application
- 8.4.2.6.4.Rest of Asia-Pacific spatial genomics and transcriptomics market, by end user
- 8.4.3.Asia-Pacific market size and forecast, by technique
- 8.4.3.1.Asia-Pacific market size and forecast, by spatial transcriptomics
- 8.4.3.2.Asia-Pacific market size and forecast, by spatial genomics analysis
- 8.4.4.Asia-Pacific market size and forecast, by product type
- 8.4.5.Asia-Pacific market size and forecast, by application
- 8.4.6.Asia-Pacific market size and forecast, by end user
- 8.5.LAMEA
- 8.5.1.Key market trends, growth factors, and opportunities
- 8.5.2.Market size and forecast, by country
- 8.5.2.1.Latin America
- 8.5.2.1.1.Latin America spatial genomics and transcriptomics market, by technique
- 8.5.2.1.2.Latin America spatial genomics and transcriptomics market, by product type
- 8.5.2.1.3.Latin America spatial genomics and transcriptomics market, by application
- 8.5.2.1.4.Latin America spatial genomics and transcriptomics market, by end user
- 8.5.2.2.Middle East and Africa
- 8.5.2.2.1.Middle East and Africa spatial genomics and transcriptomics market, by technique
- 8.5.2.2.2.Middle East and Africa spatial genomics and transcriptomics market, by product type
- 8.5.2.2.3.Middle East and Africa spatial genomics and transcriptomics market, by application
- 8.5.2.2.4.Middle East and Africa spatial genomics and transcriptomics market, by end user
- 8.5.3.LAMEA market size and forecast, by technique
- 8.5.3.1.LAMEA market size and forecast, by spatial transcriptomics
- 8.5.3.2.LAMEA market size and forecast, by spatial genomics analysis
- 8.5.4.LAMEA market size and forecast, by product type
- 8.5.5.LAMEA market size and forecast, by application
- 8.5.6.LAMEA market size and forecast, by end user
- CHAPTER 9:COMPANY PROFILES
- 9.1.10X GENOMICS, INC.
- 9.1.1.Company overview
- 9.1.2.Company snapshot
- 9.1.3.Operating business segments
- 9.1.4.Product portfolio
- 9.1.5.Business performance
- 9.2.AKOYA BIOSCIENCES, INC.
- 9.2.1.Company overview
- 9.2.2.Company snapshot
- 9.2.3.Operating business segments
- 9.2.4.Product portfolio
- 9.2.5.Business performance
- 9.2.6.Key strategic moves and developments
- 9.3.BIOSPYDER TECHNOLOGIES INC.
- 9.3.1.Company overview
- 9.3.2.Company snapshot
- 9.3.3.Operating business segments
- 9.3.4.Product portfolio
- 9.4.BIO-TECHNE CORPORATION (ADVANCED CELL DIAGNOSTICS, INC.)
- 9.4.1.Company overview
- 9.4.2.Company snapshot
- 9.4.3.Operating business segments
- 9.4.4.Product portfolio
- 9.4.5.Business performance
- 9.5.DOVETAIL GENOMICS LLC.
- 9.5.1.Company overview
- 9.5.2.Company snapshot
- 9.5.3.Operating business segments
- 9.5.4.Product portfolio
- 9.5.5.Key strategic moves and developments
- 9.6.FLUIDIGM CORPORATION
- 9.6.1.Company overview
- 9.6.2.Company snapshot
- 9.6.3.Operating business segments
- 9.6.4.Product portfolio
- 9.6.5.Business performance
- 9.6.6.Key strategic moves and developments
- 9.7.GENOMIC VISION SA
- 9.7.1.Company overview
- 9.7.2.Company snapshot
- 9.7.3.Operating business segments
- 9.7.4.Product portfolio
- 9.7.5.Business performance
- 9.8.ILLUMINA INC.
- 9.8.1.Company overview
- 9.8.2.Company snapshot
- 9.8.3.Operating business segments
- 9.8.4.Product portfolio
- 9.8.5.Business performance
- 9.8.6.Key strategic moves and developments
- 9.9.LUNAPHORE TECHNOLOGIES SA
- 9.9.1.Company overview
- 9.9.2.Company snapshot
- 9.9.3.Operating business segments
- 9.9.4.Product portfolio
- 9.10.NANOSTRING TECHNOLOGIES, INC
- 9.10.1.Company overview
- 9.10.2.Company snapshot
- 9.10.3.Operating business segments
- 9.10.4.Product portfolio
- 9.10.5.Business performance
- 9.10.6.Key strategic moves and developments
- 9.11.NATERA INC.
- 9.11.1.Company overview
- 9.11.2.Company snapshot
- 9.11.3.Operating business segments
- 9.11.4.Product portfolio
- 9.11.5.Business performance
- 9.12.PERKINELMER INC. (ADVANCED CELL DIAGNOSTICS, INC.)
- 9.12.1.Company overview
- 9.12.2.Company snapshot
- 9.12.3.Operating business segments
- 9.12.4.Product portfolio
- 9.12.5.Business performance
- 9.13.RARECYTE, INC.
- 9.13.1.Company overview
- 9.13.2.Company snapshot
- 9.13.3.Operating business segments
- 9.13.4.Product portfolio
- 9.13.5.Key strategic moves and developments
- 9.14.REBUS BIOSYSTEMS, INC.
- 9.14.1.Company overview
- 9.14.2.Company snapshot
- 9.14.3.Operating business segments
- 9.14.4.Product portfolio
- 9.14.5.Key strategic moves and developments
- 9.15.RESOLVE BIOSCIENCES
- 9.15.1.Company overview
- 9.15.2.Company snapshot
- 9.15.3.Operating business segments
- 9.15.4.Product portfolio
- 9.15.5.Key strategic moves and developments
- 9.16.S2 GENOMICS INC.
- 9.16.1.Company overview
- 9.16.2.Company snapshot
- 9.16.3.Operating business segments
- 9.16.4.Product portfolio
- 9.16.5.Key strategic moves and developments
- 9.17.SEVEN BRIDGES GENOMICS, INC.
- 9.17.1.Company overview
- 9.17.2.Company snapshot
- 9.17.3.Operating business segments
- 9.17.4.Product portfolio
- 9.18.SINGULAR GENOMICS SYSTEMS, INC.
- 9.18.1.Company overview
- 9.18.2.Company snapshot
- 9.18.3.Operating business segments
- 9.18.4.Product portfolio
- 9.18.5.Key strategic moves and developments
- 9.19.TECAN GROUP LTD. (NUGEN TECHNOLOGIES, INC.)
- 9.19.1.Company overview
- 9.19.2.Company snapshot
- 9.19.3.Operating business segments
- 9.19.4.Product portfolio
- 9.19.5.Business performance
- 9.20.ULTIVUE, INC.
- 9.20.1.Company overview
- 9.20.2.Company snapshot
- 9.20.3.Operating business segments
- 9.20.4.Product portfolio
- 9.20.5.Key strategic moves and developments
- 9.21.VERANOME BIOSYSTEMS LLC
- 9.21.1.Company overview
- 9.21.2.Company snapshot
- 9.21.3.Operating business segments
- 9.21.4.Product portfolio
- 9.22.VIZGEN CORPORATION
- 9.22.1.Company overview
- 9.22.2.Company snapshot
- 9.22.3.Operating business segments
- 9.22.4.Product portfolio
- LIST OF TABLES
- TABLE 01.GLOBAL SPATIAL GENOMICS AND TRANSCRIPTOMIC MARKET, BY TECHNIQUE, 2020-2030 ($MILLION)
- TABLE 02.SPATIAL GENOMICS AND TRANSCRIPTOMIC MARKET FOR SPATIAL TRANSCRIPTOMICS, BY REGION, 2020-2030 ($MILLION)
- TABLE 03.SPATIAL GENOMICS AND TRANSCRIPTOMIC MARKET, FOR SPATIAL TRANSCRIPTOMICS, BY TYPE, 2020–2030, ($MILLION)
- TABLE 04.SPATIAL GENOMICS AND TRANSCRIPTOMIC MARKET FOR SPATIAL GENOMICS ANALYSIS, BY REGION, 2020-2030 ($MILLION)
- TABLE 05.SPATIAL GENOMICS AND TRANSCRIPTOMIC MARKET, FOR SPATIAL GENOMICS ANALYSIS, BY TYPE, 2020–2030, ($MILLION)
- TABLE 06.GLOBAL SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
- TABLE 07.SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR INSTRUMENTS, BY REGION, 2020-2030 ($MILLION)
- TABLE 08.SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONSUMABLES, BY REGION, 2020-2030 ($MILLION)
- TABLE 09.SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR SOFTWARE, BY REGION, 2020-2030 ($MILLION)
- TABLE 10.GLOBAL SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 11.SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2020-2030 ($MILLION)
- TABLE 12.SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020-2030 ($MILLION)
- TABLE 13.GLOBAL SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 14.SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2030 ($MILLION)
- TABLE 15.SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020-2030 ($MILLION)
- TABLE 16.SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020-2030 ($MILLION)
- TABLE 17.SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY REGION, 2020-2030($MILLION)
- TABLE 18.NORTH AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2030($MILLION)
- TABLE 19.U.S. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 20.U.S. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 21.U.S. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 22.U.S. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 23.CANADA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 24.CANADA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 25.CANADA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 26.CANADA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 27.MEXICO SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 28.MEXICO SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 29.MEXICO SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 30.MEXICO SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 31.NORTH AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 32.NORTH AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY SPATIAL TRANSCRIPTOMICS, 2020-2030 ($MILLION)
- TABLE 33.NORTH AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY SPATIAL GENOMICS ANALYSIS, 2020-2030 ($MILLION)
- TABLE 34.NORTH AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 35.NORTH AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 36.NORTH AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 37.EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2030($MILLION)
- TABLE 38.GERMANY SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 39.GERMANY SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 40.GERMANY SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 41.GERMANY SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 42.FRANCE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 43.FRANCE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 44.FRANCE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 45.FRANCE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 46.UK SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 47.UK SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 48.UK SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 49.UK SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 50.ITALY SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 51.ITALY SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 52.ITALY SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 53.ITALY SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 54.SPAIN SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 55.SPAIN SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 56.SPAIN SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 57.SPAIN SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 58.REST OF EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 59.REST OF EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 60.REST OF EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 61.REST OF EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 62.EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 63.EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY SPATIAL TRANSCRIPTOMICS, 2020-2030($MILLION)
- TABLE 64.EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY SPATIAL GENOMICS ANALYSIS, 2020-2030($MILLION)
- TABLE 65.EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 66.EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 67.EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 68.ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2030($MILLION)
- TABLE 69.JAPAN SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 70.JAPAN SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 71.JAPAN SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 72.JAPAN SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 73.CHINA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 74.CHINA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 75.CHINA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 76.CHINA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 77.AUSTRALIA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 78.AUSTRALIA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 79.AUSTRALIA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 80.AUSTRALIA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 81.INDIA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 82.INDIA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 83.INDIA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 84.INDIA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 85.SOUTH KOREA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 86.SOUTH KOREA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 87.SOUTH KOREA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 88.SOUTH KOREA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 89.REST OF ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 90.REST OF ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 91.REST OF ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 92.REST OF ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 93.ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 94.ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY SPATIAL TRANSCRIPTOMICS, 2020-2030($MILLION)
- TABLE 95.ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY SPATIAL GENOMICS ANALYSIS, 2020-2030 ($MILLION)
- TABLE 96.ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 97.ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 98.ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 99.LAMEA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020-2030($MILLION)
- TABLE 100.LATIN AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 101.LATIN AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 102.LATIN AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 103.LATIN AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 104.MIDDLE EAST AND AFRICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 105.MIDDLE EAST AND AFRICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 106.MIDDLE EAST AND AFRICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 107.MIDDLE EAST AND AFRICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 108.LAMEA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
- TABLE 109.LAMEA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY SPATIAL TRANSCRIPTOMICS, 2020-2030($MILLION)
- TABLE 110.LAMEA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY SPATIAL GENOMICS ANALYSIS, 2020-2030($MILLION)
- TABLE 111.LAMEA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
- TABLE 112.LAMEA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
- TABLE 113.LAMEA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET, BY END USER, 2020-2030($MILLION)
- TABLE 114.10X GENOMICS INC.: COMPANY SNAPSHOT
- TABLE 115.10X GENOMICS: OPERATING SEGMENT
- TABLE 116.10X GENOMICS INC.: PRODUCT PORTFOLIO
- TABLE 117.AKOYA BIOSCIENCES INC.: COMPANY SNAPSHOT
- TABLE 118.AKOYA BIOSCIENCES: PRODUCT SEGMENTS
- TABLE 119.AKOYA BIOSCIENCES INC.: PRODUCT PORTFOLIO
- TABLE 120.AKOYA BIOSCIENCES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 121.BIOSPYDER TECHNOLOGIES: COMPANY SNAPSHOT
- TABLE 122.BIOSPYDER TECHNOLOGIES: OPERATING SEGMENTS
- TABLE 123.BIOSPYDER TECHNOLOGIES: PRODUCT PORTFOLIO
- TABLE 124.BIO-TECHNE CORPORATION: COMPANY SNAPSHOT
- TABLE 125.BIO-TECHNE CORPORATION: OPERATING SEGMENT
- TABLE 126.BIO-TECHNE CORPORATION: PRODUCT PORTFOLIO
- TABLE 127.DOVETAIL GENOMICS LLC: COMPANY SNAPSHOT
- TABLE 128.DOVETAIL GENOMICS LLC: OPERATING SEGMENTS
- TABLE 129.DOVETAIL GENOMICS LLC: PRODUCT PORTFOLIO
- TABLE 130.DOVETAIL GENOMICS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 131.FLUIDIGM CORPORATION : COMPANY SNAPSHOT
- TABLE 132.FLUIDIGM CORPORATION : OPERATING SEGMENTS
- TABLE 133.FLUIDIGM CORPORATION : PRODUCT PORTFOLIO
- TABLE 134.FLUIDIGM: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 135.GENOMIC VISION SA: COMPANY SNAPSHOT
- TABLE 136.GENOMIC VISION SA: OPERATING SEGMENTS
- TABLE 137.GENOMIC VISION SA: PRODUCT PORTFOLIO
- TABLE 138.ILLUMINA, INC.: COMPANY SNAPSHOT
- TABLE 139.ILLUMINA, INC.: OPERATING SEGMENTS
- TABLE 140.ILLUMINA, INC.: PRODUCT PORTFOLIO
- TABLE 141.ILUMINA INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 142.LUNAPHORE TECHNOLOGIES SA.: COMPANY SNAPSHOT
- TABLE 143.LUNAPHORE TECHNOLOGIES SA: OPERATING SEGMENTS
- TABLE 144.LUNAPHORE TECHNOLOGIES SA: PRODUCT PORTFOLIO
- TABLE 145.NANOSTRING TECHNOLOGIES INC.: COMPANY SNAPSHOT
- TABLE 146.NANOSTRING TECHNOLOGIES INC.: OPERATING SEGMENTS
- TABLE 147.NANOSTRING TECHNOLOGIES INC.: PRODUCT PORTFOLIO
- TABLE 148.NANOSTRING TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 149.NATERA INC.: COMPANY SNAPSHOT
- TABLE 150.NATERA INC.: OPERATING SEGMENTS
- TABLE 151.NATERA INC.: PRODUCT PORTFOLIO
- TABLE 152.PERKINELMER INC.: COMPANY SNAPSHOT
- TABLE 153.PERKINELMER INC.: OPERATING SEGMENTS
- TABLE 154.PERKIN ELMER: PRODUCT PORTFOLIO
- TABLE 155.RARECYTE, INC.: COMPANY SNAPSHOT
- TABLE 156.RARECYTE, INC.: OPERATING SEGMENTS
- TABLE 157.RARECYTE, INC.: PRODUCT PORTFOLIO
- TABLE 158.RARECYTE, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 159.REBUS BIOSYSTEMS INC.: COMPANY SNAPSHOT
- TABLE 160.REBUS BIOSYSTEMS: OPERATING SEGMENTS
- TABLE 161.REBUS BIOSYSTEMS: PRODUCT PORTFOLIO
- TABLE 162.REBUS BIOSYSTEMS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 163.RESOLVE BIOSCIENCES.: COMPANY SNAPSHOT
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook